Barclays PLC Boosts Holdings in Cartesian Therapeutics, Inc. (NASDAQ:RNAC)
Barclays PLC grew its holdings in Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) by 64.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,099 shares of the company’s stock after buying an additional 7,488 shares during the quarter. Barclays PLC’s holdings in […]
Barclays PLC grew its holdings in Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) by 64.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,099 shares of the company’s stock after buying an additional 7,488 shares during the quarter. Barclays PLC’s holdings in […]
